A detailed history of Paradigm Biocapital Advisors LP transactions in Compass Pathways PLC stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 1,160,000 shares of CMPS stock, worth $9.91 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,160,000
Previous 2,335,926 50.34%
Holding current value
$9.91 Million
Previous $19.9 Million 50.34%
% of portfolio
0.36%
Previous 0.81%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-1,175,926 Reduced 50.34%
1,160,000 $9.91 Million
Q2 2024

Aug 14, 2024

SELL
N/A
-55,062 Reduced 2.3%
2,335,926 $19.9 Million
Q1 2024

May 15, 2024

BUY
N/A
125,000 Added 5.52%
2,390,988 $20.4 Million
Q4 2023

Feb 14, 2024

BUY
N/A
907,279 Added 66.78%
2,265,988 $19.4 Million
Q3 2023

Nov 14, 2023

BUY
N/A
1,358,709 New
1,358,709 $11.6 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.